Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Tirzepatide is a dual-action injectable medication that targets both: This dual mechanism is what separates tirzepatide from semaglutide and explains why many patients experience: Brand-name versions include Mounjaro and Zepbound , depending on indication and insurance coverage
Supply chain scramble Eli Lilly, whose Mounjaro and Zepbound are tirzepatide formulations for diabetes and weight management, respectively, is struggling to produce enough of the therapy even as it expects to ramp up production volume 50% in the first half of 2024 compared to the same period in 2023
The list prices remain high, but the effective price many people pay has been falling
This decision ultimately depends on personal comfort, lifestyle, and insurance coverage
Further analysis was done by calculating the percentage of mean changes from the outcome variables at 5 and 10 weeks
